At a glance
- Originator Uriach
- Class Antiplatelets
- Mechanism of Action Platelet activating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Septic shock
Most Recent Events
- 21 Dec 2001 Discontinued-Preclinical for Septic shock in Spain (Unknown route)
- 06 Aug 1999 New profile
- 06 Aug 1999 Preclinical development for Septic shock in Spain (Unknown route)